{
    "2020-06-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "A Yes Vote for AMD Stock",
                "features": {
                    "keywords": [
                        "AMD",
                        "vote"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Top Analyst Reports for AbbVie, Oracle & GlaxoSmithKline",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Oracle",
                        "GlaxoSmithKline",
                        "analyst reports"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "AbbVie Stock Has More Upside, Analyst Says",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "upside",
                        "analyst"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "The Zacks Analyst Blog Highlights: Eli Lilly & Company, AstraZeneca, AbbVie and Bristol-Myers Squibb",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Eli Lilly",
                        "AstraZeneca",
                        "AbbVie",
                        "Bristol-Myers Squibb"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Is AbbVie (ABBV) Stock Undervalued Right Now?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "undervalued"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-25",
                "original_text": "Alpine Skyrockets on License Deal With AbbVie for ALPN-101",
                "features": {
                    "keywords": [
                        "Alpine",
                        "license deal",
                        "AbbVie",
                        "ALPN-101"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs",
                "features": {
                    "keywords": [
                        "Tiziana",
                        "patent win",
                        "Nabriva",
                        "Evoke",
                        "IPOs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-22",
                "original_text": "Pharma Stock Roundup: FDA Approvals to MRK, LLY, NVS and GSK's Drugs",
                "features": {
                    "keywords": [
                        "FDA approvals",
                        "MRK",
                        "LLY",
                        "NVS",
                        "GSK"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}